BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3339366)

  • 21. Effects of thio-group modifications of Torpedo californica acetylcholine receptor on ion flux activation and inactivation kinetics.
    Walker JW; Richardson CA; McNamee MG
    Biochemistry; 1984 May; 23(11):2329-38. PubMed ID: 6089867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of nicotine response in four inbred strains of mice.
    Marks MJ; Burch JB; Collins AC
    J Pharmacol Exp Ther; 1983 Jul; 226(1):291-302. PubMed ID: 6864548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of nicotine-like receptor-ligand interactions in rodent brain homogenate.
    Larsson C; Nordberg A
    J Neurochem; 1985 Jul; 45(1):24-31. PubMed ID: 3998724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nereistoxin: a naturally occurring toxin with redox effects on neuronal nicotinic acetylcholine receptors in chick retina.
    Xie Y; Lane WV; Loring RH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):689-94. PubMed ID: 8437117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage of strain-specific nicotinic receptor alpha 7 subunit restriction fragment length polymorphisms with levels of alpha-bungarotoxin binding in brain.
    Stitzel JA; Farnham DA; Collins AC
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):30-40. PubMed ID: 9037516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
    Sugaya K; Giacobini E; Chiappinelli VA
    J Neurosci Res; 1990 Nov; 27(3):349-59. PubMed ID: 2097379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 125I-Labeled alpha-bungarotoxin and [3H]quinuclidinylbenzilate binding to rat brain membranes. Effects of physical, chemical and enzymatic treatments.
    Salvaterra PM
    Biochim Biophys Acta; 1980 Sep; 601(1):78-91. PubMed ID: 6773577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions.
    Fiedler EP; Marks MJ; Collins AC
    Int J Dev Neurosci; 1990; 8(5):533-40. PubMed ID: 2281814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent modification of engineered cysteines in the nicotinic acetylcholine receptor agonist-binding domain inhibits receptor activation.
    McLaughlin JT; Hawrot E; Yellen G
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):765-9. PubMed ID: 7575408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype influences the development of tolerance to nicotine in the mouse.
    Marks MJ; Campbell SM; Romm E; Collins AC
    J Pharmacol Exp Ther; 1991 Oct; 259(1):392-402. PubMed ID: 1920127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic cholinergic receptor in brain detected by binding of alpha-(3 H) bungarotoxin.
    Eterović VA; Bennett EL
    Biochim Biophys Acta; 1974 Sep; 362(2):346-55. PubMed ID: 4424687
    [No Abstract]   [Full Text] [Related]  

  • 34. Probing the agonist domain of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis reveals residues in proximity to the alpha-bungarotoxin binding site.
    Spura A; Russin TS; Freedman ND; Grant M; McLaughlin JT; Hawrot E
    Biochemistry; 1999 Apr; 38(16):4912-21. PubMed ID: 10213592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential binding of nicotine and alpha-bungarotoxin to residues 173-204 of the nicotinic acetylcholine receptor alpha 1 subunit.
    Lentz TL
    Biochemistry; 1995 Jan; 34(4):1316-22. PubMed ID: 7827079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain.
    Quik M; Babu U; Audhya T; Goldstein G
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2603-7. PubMed ID: 1848710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of thio-group modification and Ca2+ on agonist-specific state transitions of a central nicotinic acetylcholine receptor.
    Lukas RJ; Morimoto H; Bennett EL
    Biochemistry; 1979 May; 18(11):2384-95. PubMed ID: 444464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of reduction and alkylation on ligand binding and cation transport by Torpedo californica acetylcholine receptor.
    Blanchard SG; Dunn SM; Raftery MA
    Biochemistry; 1982 Nov; 21(24):6258-64. PubMed ID: 7150555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrangement of the subunits of the nicotinic acetylcholine receptor of Torpedo californica as determined by alpha-neurotoxin cross-linking.
    Hamilton SL; Pratt DR; Eaton DC
    Biochemistry; 1985 Apr; 24(9):2210-9. PubMed ID: 3995011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.
    Damaj MI; Fonck C; Marks MJ; Deshpande P; Labarca C; Lester HA; Collins AC; Martin BR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1161-9. PubMed ID: 17371806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.